Peroxynitrite induces formation of Nε-(carboxymethyl)lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: Novel pathways for protein modification by peroxynitrite

Diabetes

Volumn 51, Issue 9, 2002, Pages 2833-2839

  Nagai, Ryoji ^a   Unno, Yuka ^a,b   Hayashi, Miki Cristina ^a   Masuda, Shuichi ^b   Hayase, Fumitaka ^c   Kinae, Naohide ^b   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c MEIJI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE; AMINOGUANIDINE; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; GLUCOSONE; GLYOXAL; HUMAN SERUM ALBUMIN; NAPHTHALENE DERIVATIVE; PEROXYNITRITE; REAGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION;

EID: 0036724199     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.9.2833     Document Type: Article

References (42)

1. Nε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
2. Nε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
3. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
4. Immunofluorescence staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus using monoclonal antibody to reduced glycated lysine
5. Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy
6. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas
7. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody
8. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions
9. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease
10. Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
11. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
12. Nitric oxide: An endogenous modulator of leukocyte adhesion
13. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells
14. Role of endothelium-derived nitric oxide in the regulation of blood pressure
15. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
16. Peroxynitrite-mediated oxidative protein modifications
17. Nitric oxide and oxygen radicals: A question of balance
18. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
19. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells
20. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: Evidence for the presence of a common structure
21. Glycolaldehyde, a reactive intermediate for advanced glycation endproducts, plays an important role in the generation of an active ligand for the macrophage scavenger receptor
22. Effect of diabetes and aging on carboyymethyllysine levels in human urine
23. Hydroxyl radical mediates Nε-(carboxymethyl)lysine formation from Amadori product
24. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction
25. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose
26. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
27. Chemical pathways of the Maillard reaction. The Maillard reaction in food processing
28. 2,3-Diaminonaphthalene as a spectrometric and fluorometric reagent for the determination of nitrite ion
29. Selective oxidation of histidine residues in proteins or peptides through the copper(II)-catalysed autoxidation of glucosone
30. Formation of glyoxal, methyl-glyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
31. Insulin down-regulates the inducible nitric oxide synthase pathway: Nitric oxide as cause and effect of diabetes?
32. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
33. Superoxide production from nonenzymatically glycated protein
34. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions: Studies with the model fructosamine, Nε-(1-deoxy-D-fructos-1-yl)hippuryl-lysine
35. Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress
36. Oxidative chemistry of nitric oxide: The roles of superoxide, peroxynitrite, and carbon dioxide
37. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide
38. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
39. Peroxynitrite formation from macrophage-derived nitric oxide
40. The chemistry of peroxymtrite: A product from the reaction of nitric oxide with superoxide
41. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: Aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli